NEW PRODUCT: Nypozi for several neutropenia-related indicationsGet the info you need on this new product, part of our drug news roundup for May. First vaccine to prevent RSV in infants by immunizing pregnant individuals now available in CanadaAbrysvo is also indicated for active immunization of individuals ≥ 60 years of age to prevent lower respiratory tract disease caused by RSV. NEW PRODUCT: Ranopto for neovascular age-related macular degeneration and more Get the info you need on this new product, part of our drug news roundup for May. Rexall named one of the Best Workplaces in Canada for 2024 Five other Canadian healthcare companies also made the 2024 list of the Best Workplaces in Canada with over 1,000 employees. ‘Prepared’: How Canada’s clinicians and scientists are looking ahead to the next potential pandemic One of the 19 projects in the works is a national network of existing emergency departments and primary-care clinics, called Prepared. Toronto pharmacist chosen for Women4Climate mentorship program Janet Chong-Lee won for her company, VialCycle, which offers reusable glass vials to pharmacies. AstraZeneca to buy Canadian cancer treatment developer Fusion Pharmaceuticals Fusion, based in Hamilton, is focused on developing radioconjugates which are used to deliver radiation directly to cancer cells. Older, immunocompromised people may get COVID-19 vaccine dose in spring, NACI says The advisory committee is issuing the spring recommendation now to help public health vaccine program planning. Health Canada approves RSV vaccine for use in pregnancy to immunize infants Pfizer says the vaccine, called Abrysvo, is also approved for adults aged 60 and older. Novavax vaccine for COVID XBB variant now ready for distribution Doses of Nuvaxovid have been delivered to the Public Health Agency of Canada, Novavax said in a press release. First Previous 2 3 4 5 6 Next Last
